Our results revealed that TSL treatment increased the levels of proapoptotic proteins Bax and Puma, while it decreased the levels of antiapoptotic Bcl-2 in both GBM cell lines (A172 and U251) (Fig 5A). This evidence concerns the gene BBC3 and glioblastoma.